Latest filing published 11 Mar 2021 for Marinus Pharmaceuticals, INC., €126k.
Filing timeline
BuySaleInsider track record
Edward F. Smith: trading record in brief
Edward F. Smith discloses dealings in Marinus Pharmaceuticals, Inc. to SEC (Form 4). The record holds 8 filings, for trades running from 3 August 2016 to 9 March 2021.
No open-market purchase appears, only 5 sales worth €745k. Outside the open market, there are 2 share grants and 1 option exercise. Since January 2021: no purchases and 1 sale on the market.
The record was last updated on 11 March 2021 with an option exercise (€126k) in Marinus Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Edward F. Smith
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 35,927 shares@ US$4.1614.5% of flowCommon StockSEC:0001104659-21-034993:0
- 40,356 shares@ US$17.8069.6% of flowCommon StockSEC:0001104659-21-034993:1
- 2,380 shares@ US$2.053.7% of flowCommon stockSEC:0001104659-20-009947:0
- 24,211 shares@ US$5.0390.8% of flowCommon stockSEC:0001104659-19-030563:0
- 2,492 shares@ US$3.064.8% of flowCommon stockSEC:0001104659-19-004457:0
- 25,200 sharesCommon stockSEC:0001104659-18-004809:0
- 27,600 sharesCommon stockSEC:0001104659-18-004812:0
- 3,000 shares@ US$7.9113.7% of flowCommon stockSEC:0001104659-18-004810:0
8 of 8 declarations
